ilmscore | Prediction Details
"we are raising our fouryear Revenue range by $1 billion and our adjusted diluted earnings per share by 30 C we now expect revenues in the range of 59.5 to 62.5 billion dollar and operational Revenue growth excluding Co project products is now projected to be 9 to 11% Co product revenues are now expected to be 8 a. half billion dollar for the year5 billion for commodity and $ three and A5 billion dollar for PA lovit our guidance for adjusted sin and adjusted R&D remains Unchained while our effective tax rate on adjusted income is now expected to be approximately 133% and lastly we expected just a diluted earnings per share of $245 to $265 primarily reflecting the increase to the Topline and the revised tax rate among other items"
By Stock Market Live | July 30, 2024 | Pending
From video
MSFT & AMD EARNINGS 01:56:08 - 01:57:21
Interpreted Prediction
Pfizer (PFE) updated its full-year 2024 guidance: revenue to $59.5-$62.5 billion, operational revenue growth (ex-COVID) to 9-11%, COVID product revenue to $8.5 billion (Comirnaty $5 billion, Paxlovid $3.5 billion), adjusted tax rate to ~13%, and adjusted diluted EPS to $2.45-$2.65.

Prediction Details

Ticker
PFE

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.